Загрузка...
Co-administration of epithelial junction opener JO-1 improves the efficacy and safety of chemotherapeutic drugs
PURPOSE: Epithelial junctions between tumor cells inhibit the penetration of anti-cancer drugs into tumors. We previously reported on recombinant adenovirus serotype 3 derived protein (JO-1), which triggers transient opening of intercellular junctions in epithelial tumors through binding to desmogle...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3547677/ https://ncbi.nlm.nih.gov/pubmed/22535153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-3213 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|